Pei-Jung Lin, PhD

Articles

December 11th 2019

Outcome Measures for Oncology Alternative Payment Models: Practical Considerations and Recommendations

Jakub P. Hlávka, PhD Pei-Jung Lin, PhD Peter J. Neumann, ScD

This review presents a set of evidence-based outcome measures for oncology alternative payment models, drawing on evidence from existing and proposed quality measures.

February 27th 2015

Multiple Chronic Conditions in Type 2 Diabetes Mellitus: Prevalence and Consequences

Pei-Jung Lin, PhD David M. Kent, MD, MSc Aaron Winn, MPP Joshua T. Cohen, PhD Peter J. Neumann, ScD

This study's findings showed that diabetes care remained suboptimal among many patients with multiple chronic conditions and that patient outcomes varied by multimorbidity profile.

March 9th 2010

Risk Adjustment for Medicare Beneficiaries With Alzheimer's Disease and Related Dementias

Pei-Jung Lin, PhD Matthew L. Maciejewski, PhD John E. Paul, PhD and Andrea K. Biddle, PhD

Incorporating functional status in diagnosis-based risk adjustment measures may modestly improve overall expenditure prediction for beneficiaries with substantial disabilities, but not prescription cost prediction.

May 1st 2008

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

Muta M. Issa, MD, MBA Pei-Jung Lin, PhD Michael T. Eaddy, PharmD, PhD Manan B. Shah, PharmD, PhD E. Anne Davis, PharmD, MS

May 1st 2008

Dutasteride vs Finasteride: Assessment of Differences in Acute Urinary Retention Rates and Surgical Risk Outcomes in an Elderly Population Aged ≥65 Years

Thomas C. Fenter, MD E. Anne Davis, PharmD, MS Manan B. Shah, PharmD, PhD Pei-Jung Lin, PhD